ArticleJournal of thoracic disease2019

Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer.

Yu-Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.